Medicine and Dentistry
Neuroendocrine Tumor
100%
Quality of Life
69%
Neoplasm
55%
Carcinoid
35%
Cancer Treatment
35%
Liver Transplantation
34%
Carcinoid Syndrome
30%
Malignant Neoplasm
28%
Diseases
25%
Pancreas Islet Cell Tumor
25%
Systematic Review
20%
Cholangiocarcinoma
20%
Liver Metastasis
18%
Peptide Receptor
18%
Crohn's Disease
15%
Somatostatin Derivative
13%
Octreotide
13%
Radionuclide Therapy
12%
Liver Graft
11%
Telotristat Ethyl
11%
Diarrhea
11%
Edetic Acid
10%
Metastatic Carcinoma
10%
Chromium 51
10%
Everolimus
10%
Nodular Regenerative Hyperplasia
10%
Inflammatory Bowel Disease
10%
High Intensity Interval Training
10%
Primary Sclerosing Cholangitis
10%
Moderate-Intensity Continuous Training
9%
Randomized Controlled Trial
7%
Quality of Life Measure
7%
Lutetium 177
7%
Disease Exacerbation
7%
Colon
7%
Liver Fibrosis
7%
Overall Survival
7%
Midgut
6%
Granulomatosis
6%
Ulcerative Colitis
6%
Cancer Registry
6%
Radiology
6%
Vein Blood Flow
6%
Pathophysiology
6%
Cancer
6%
Arm
6%
Serotonin
6%
(3 Iodobenzyl)guanidine
6%
Symptomatic Treatment
6%
Chronic Graft Rejection
6%
Pharmacology, Toxicology and Pharmaceutical Science
Neuroendocrine Tumor
52%
Carcinoid Syndrome
30%
Neoplasm
29%
Duodenum Ulcer
24%
Carcinoid
20%
Telotristat Ethyl
17%
Somatostatin Derivative
16%
Cimetidine
15%
Malignant Neoplasm
15%
Pancreas Islet Cell Tumor
13%
Ranitidine
12%
Everolimus
11%
Placebo
11%
Octreotide
11%
Diseases
10%
Ethylenediaminetetraacetic Acid
10%
Remission
10%
Chromium 51
10%
Inflammatory Bowel Disease
10%
Diarrhea
10%
Inflammation
9%
Receptor
7%
Radioisotope
7%
Histamine H2 Receptor Antagonist
7%
Lutetium 177
7%
Ulcerative Colitis
7%
Disease Exacerbation
6%
Adverse Event
6%
Sunitinib
6%
Serotonin
6%
Clinical Trial
6%
Telotristat Etiprate
5%
Infection
5%
Progression Free Survival
5%
Autoimmune Hepatitis
5%
Hepatitis C
5%
Enteropathy
5%
Syndrome
5%
Placebo-Controlled Study
5%
Gastroenteropancreatic Neuroendocrine Tumor
5%
Enprostil
5%
Corticotropin
5%
Ribavirin
5%
Liver Graft Rejection
5%
Activated Protein C Resistance
5%
Pasireotide
5%
Phase IV Trials
5%
Pirenzepine
5%
Pathophysiology
5%
Colon Disease
5%
Nursing and Health Professions
Quality of Life
49%
Malignant Neoplasm
32%
Neoplasm
17%
Carcinoid Syndrome
15%
Neuroendocrine Tumor
12%
Telotristat Ethyl
11%
Bile Duct Carcinoma
10%
Systematic Review
10%
Carcinoid
10%
Diarrhea
7%
Quality of Life Measure
6%
Diseases
6%
Clinical Practice
6%
Patient-Reported Outcome
5%
Placebo-Controlled Study
5%
Survivorship in Cancer Care
5%
High-Intensity Interval Training
5%
Palliative Therapy
5%
Crohn's Disease
5%
Pancreas Islet Cell Tumor
5%
Gallbladder Cancer
5%
Ki 67 Antigen
5%
Colorectal Liver Metastasis
5%
Liver Transplantation
5%
Post Hoc Analysis
5%
